查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1804579

医疗设备中的萤光（按技术、磷光体类型、应用和最终用户）—2025-2030 年全球预测

Fluorescence in Medical Device Market by Technology, Fluorophore Type, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2024年医疗设备萤光市场规模将达48.1亿美元，2025年将成长至52.5亿美元，复合年增长率为9.45%，到2030年将达到82.8亿美元。

主要市场统计数据
基准年2024年 48.1亿美元
预计2025年 52.5亿美元
预测年份 2030 82.8亿美元
复合年增长率（%） 9.45%

透过基本观点、新兴趋势和塑造医疗技术格局的关键驱动因素，阐明医疗设备萤光的未来

萤光技术在临床影像和诊断应用中具有无与伦比的敏感度和特异性，已成为医疗设备创新的关键。透过利用特定波长激发的磷光体团的独特光学特征，开发人员可以以惊人的精度可视化组织结构、指导手术干预并监测治疗反应。这项基础技术彻底改变了传统的诊断方法，透过微创手术和即时视觉化功能改善了患者的治疗效果。

透过技术突破、监管演变和临床应用趋势追踪医学萤光应用的变革

近年来，一系列技术突破推动了医疗设备中萤光的发展，这些突破重新定义了诊断和治疗的可能性。萤光成像系统的创新实现了更高的空间分辨率和更深的组织穿透能力，而光谱技术的进步则增强了对生物分子相互作用的定量分析。同时，新型萤光染料和药物的光稳定性和标靶递送机制的改进，拓展了萤光在各种临床环境中的应用范围。这些技术飞跃与人工智慧和机器学习演算法的整合相辅相成，优化了讯号解读并减少了对操作员的依赖，从而提高了工作流程效率和诊断准确性。

2025年美国关税调整计画对医疗设备萤光供应链与定价动态的累积影响分析

美国政府2025年关税计画的实施对医疗设备萤光产业而言正值关键时刻。这些调整涵盖了各种进口组件，从光学滤光片和光源到专用萤光染料和成像模组，不一而足。因此，製造商可能面临进口关税上调，从而可能增加原材料和成品的成本。预计这些关税变化的累积影响将透过供应链结构的变化体现出来，包括供应商组合的潜在转变以及更注重国内生产以降低成本风险。此外，关税变化也促使相关人员重新评估其长期筹资策略，并评估垂直整合製造流程的可行性。

从萤光市场技术、磷光体类型、应用模式和最终用户垂直领域的垂直细分中获得关键见解

依技术细分萤光市场，可以揭示成像系统、光谱平台以及萤光染料和试剂等细分领域中不同的成长动力和应用。萤光成像系统因其提供即时视觉回馈的能力，在手术室中越来越受欢迎，而光谱技术的进步则支持在实验室中进行详细的分子分析。同时，萤光染料和试剂也不断发展，提高光稳定性和标靶特异性，进而增强诊断准确性和治疗监测。这种基于技术的观点使相关人员能够识别创新最集中的领域以及仍需关注的技术障碍。

了解美洲、中东和非洲以及亚太地区的区域动态和成长模式，推动策略市场扩张

美洲地区的区域动态持续受到北美医疗基础设施强劲投资和重要创新丛集的影响。美国在萤光医疗设备开发方面处于领先地位，并得到了强大的创业投资资金、大学研究和优惠的报销模式的支持。加拿大紧随其后，在国家卫生优先事项和合作研究倡议的推动下，其采用率不断提高。在拉丁美洲市场，经济波动和监管分歧既带来了挑战，也带来了机会。为了满足主要城市中心对先进诊断和外科解决方案日益增长的需求，当地製造商正在逐步采用萤光技术。

重点介绍医疗设备萤光领域主要参与者的竞争策略和创新，以发掘差异化和合作的机会

萤光医疗设备领域的主要企业已展示出各种策略方法，以保持竞争优势并促进创新。领先的设备製造商优先透过内部开发和收购专业技术公司来扩展其萤光成像产品组合。透过将下一代检测器和人工智慧主导的软体整合到现有平台中，这些公司提高了诊断准确性并简化了临床工作流程。同时，化学品供应商正在投资开发具有卓越生物相容性和伙伴关係能力的先进萤光染料，并与设备製造商合作开发符合严格监管要求的整合解决方案。

为产业领导者提供策略建议，以加速创新、适应法规并加强萤光技术的市场地位

为了充分利用不断发展的萤光技术，产业领导者应采取多管齐下的策略，在创新与营运韧性之间取得平衡。首先，透过多元化零件采购和发展区域製造中心来增强供应链的稳健性，可以降低关税波动和物流中断带来的风险。同时，针对性地投资下一代萤光染料和模组化成像平台的研发，可以帮助企业保持临床创新的领先地位，并增强其应对复杂诊断和治疗挑战的能力。

调查方法强调主要和次要研究资料的收集、检验过程和分析框架，以深入了解萤光市场

本报告背后的调查方法结合了严谨的一手资料和二手资料收集，以确保全面涵盖并深入洞察。一手资料研究包括与关键意见领袖（包括生物医学工程师、临床医生、监管专家和采购经理）进行结构化访谈。此外，我们还对设备製造商、化学品供应商和最终用户进行了调查，以获得有关性能标准、应用驱动因素和市场挑战的第一手见解。这些定性资讯检验了萤光技术开发和商业化中新兴的主题。

综合关键发现并预测策略意义，以引导相关人员实现萤光的未来创新和永续成长

本执行摘要提炼了医疗设备萤光领域最具影响力的发展，重点介绍了成像系统、光谱学和磷光体设计的技术突破。摘要也检验了即将到来的关税调整及其重塑供应链和成本结构的可能性。本报告对技术、萤光团类型、应用领域和最终用户群体进行了細項分析，提供了对市场重点的细緻观点。区域洞察详细介绍了美洲、中东和非洲以及亚太地区的不同动态。竞争分析重点介绍了领先公司如何利用伙伴关係、本地生产和产品创新来保持竞争优势。切实可行的建议为应对复杂的监管环境、增强韧性和推动持续创新提供了清晰的蓝图。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章市场动态

  • 扩展近红外线萤光探针用于肿瘤学应用中的深层组织成像
  • 将近红外线萤光成像与机器人手术系统相结合可增强肿瘤可视化
  • 引进人工智慧萤光分析软体，增强组织分化
  • 新兴可穿戴萤光生物感测器，用于持续监测代谢生物标记
  • 医院与生物技术公司合作商业化新型萤光显影剂
  • 肿瘤学中实时术中萤光引导肿瘤边缘检测工具的进展
  • 结合萤光和超音波的双模临床成像平台的开发
  • 用于血管映射和皮肤病学评估的手持萤光成像设备的增长
  • 监管协调和标准化工作推动萤光医疗设备的全球商业化
  • 微创诊断程序中对3D萤光显微镜的需求不断增加

第六章 市场洞察

  • 波特五力分析
  • PESTEL分析

第七章 2025年美国关税的累积影响

第八章医疗设备市场中的萤光（依技术）

  • 萤光成像系统
  • 萤光光谱法
  • 萤光染料和萤光

第九章医疗设备市场中的萤光磷光体

  • 内源性磷光体
  • 外在磷光体

第 10 章。医疗设备市场中的萤光（依应用）

  • 导管萤光
  • 萤光导航手术
    • 心血管外科
    • 神经外科
    • 外科肿瘤学
    • 整形外科
  • 影像学诊断
    • 内视镜萤光成像
    • 萤光显微镜
    • 基于萤光的眼科成像
    • 体内萤光成像
  • 治疗

第 11 章。医疗设备市场中的萤光（依最终用户）

  • 诊断实验室
  • 医院和诊所
  • 研究和学术机构

12.美国医疗设备萤光市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

13. 欧洲、中东和非洲医疗设备萤光市场

  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 阿拉伯聯合大公国
  • 沙乌地阿拉伯
  • 南非
  • 丹麦
  • 荷兰
  • 卡达
  • 芬兰
  • 瑞典
  • 奈及利亚
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波兰
  • 瑞士

14. 亚太地区医疗设备萤光市场

  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 印尼
  • 泰国
  • 菲律宾
  • 马来西亚
  • 新加坡
  • 越南
  • 台湾

第十五章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • ADVACAM sro
    • Arthrex, Inc.
    • Bruker Corporation
    • Carl Zeiss AG.
    • Getinge AB
    • Hamamatsu Photonics KK
    • KARL STORZ SE & Co. KG
    • Leica Microsystems GmbH
    • LI-COR Biotech, LLC
    • Mauna Kea Technologies
    • Medtronic International Trading Sarl
    • MolecuLight Inc.
    • Olympus Corporation of the Americas
    • OnLume Inc.
    • Optomedic.
    • PerkinElmer US LLC
    • PicoQuant GmbH
    • Shimadzu Corporation
    • Stryker Corporation
    • Xuzhou Hengjia Electronic Technology Co., Ltd.
    • SurgiMab SAS

第十六章 研究人工智慧

第十七章 研究统计

第十八章 研究联络人

第十九章 研究报导

第二十章 附录

Product Code: MRR-4545435F211F

The Fluorescence in Medical Device Market was valued at USD 4.81 billion in 2024 and is projected to grow to USD 5.25 billion in 2025, with a CAGR of 9.45%, reaching USD 8.28 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 4.81 billion
Estimated Year [2025] USD 5.25 billion
Forecast Year [2030] USD 8.28 billion
CAGR (%) 9.45%

Illuminating the Future of Medical Device Fluorescence Through Foundational Perspectives, Emerging Trends, and Key Drivers Shaping Healthcare Technology Landscape

Fluorescence technology has emerged as a cornerstone of innovation in the medical device sector, offering unparalleled sensitivity and specificity in clinical imaging and diagnostic applications. By harnessing the unique optical signatures of fluorophores when excited by specific wavelengths of light, developers can visualize tissue structures, guide surgical interventions, and monitor therapeutic responses with remarkable accuracy. This foundational technique has transformed traditional diagnostic modalities, driving enhanced patient outcomes through minimally invasive procedures and real-time visualization capabilities.

Moreover, the convergence of advances in imaging systems, spectroscopy techniques, and specialized fluorescent agents has ushered in a new era of medical device design. Recent developments in high-resolution imaging platforms, coupled with the integration of endogenous and exogenous fluorophores, have expanded the utility of fluorescence across a range of clinical settings. As a result, practitioners are now equipped to identify pathological changes at the cellular level, enabling earlier detection of disease and more precise intervention strategies. Simultaneously, regulatory frameworks have adapted to accommodate these innovations, balancing rigorous safety assessments with accelerated pathways for breakthrough technologies.

As the landscape evolves, this executive summary offers a structured overview of the critical factors shaping the medical device fluorescence market. It synthesizes transformative shifts, examines potential headwinds from tariff adjustments, and derives strategic insights from segmented market perspectives. The analysis also delves into regional dynamics, highlights key corporate strategies, and articulates actionable recommendations. Stakeholders will gain clarity on segmentation nuances, regional growth trajectories, and pathways to competitive differentiation, empowering data-driven decision-making in an increasingly complex landscape.

Tracking the Transformative Shifts Driven by Technological Breakthroughs, Regulatory Evolution, and Clinical Adoption Trends in Medical Fluorescence Applications

In recent years, medical device fluorescence has been propelled by a series of technological breakthroughs that are redefining diagnostic and therapeutic possibilities. Innovations in fluorescence imaging systems have delivered higher spatial resolution and deeper tissue penetration, while advances in spectroscopic methodologies have enhanced quantitative analysis of biomolecular interactions. At the same time, the development of novel fluorescent dyes and agents with improved photostability and targeted delivery mechanisms has widened the applicability of fluorescence across diverse clinical scenarios. These technical leaps are complemented by integration of artificial intelligence and machine learning algorithms, which optimize signal interpretation and reduce operator dependency, thereby improving workflow efficiency and diagnostic precision.

Regulatory frameworks have also undergone significant transformation to accommodate the pace of innovation. Updated guidelines and accelerated approval pathways have enabled faster clinical adoption of fluorescence-enabled devices, while ensuring patient safety through rigorous validation requirements. Moreover, evolving reimbursement policies are beginning to recognize the value proposition of fluorescence-guided interventions, incentivizing adoption in both large hospital systems and specialized diagnostic laboratories. Consequently, clinicians are increasingly integrating fluorescence modalities into routine practice, leveraging real-time visualization during surgery or minimally invasive procedures to minimize complications and enhance patient outcomes.

In parallel, advancements in material sciences are driving next-generation fluorophores that offer enhanced biocompatibility and multiplexing capabilities, while the proliferation of portable, point-of-care imaging devices is extending fluorescence benefits to resource-limited settings worldwide. This confluence of technological, regulatory, and clinical dynamics is charting a transformative trajectory for fluorescence in medical devices, compelling industry participants to innovate and collaborate in order to capitalize on emerging applications.

Analyzing the Cumulative Impact of United States Tariff Adjustments Scheduled for 2025 on Medical Device Fluorescence Supply Chains and Pricing Dynamics

The United States government's introduction of revised tariff schedules for 2025 marks a critical juncture for the medical device fluorescence industry. These adjustments encompass a range of imported components, from optical filters and light sources to specialized fluorophores and imaging modules. As a result, manufacturers face escalating import duties that could elevate the cost of raw materials and finished devices. The cumulative effect of these tariff changes is expected to manifest through altered supply chain structures, with potential shifts in supplier portfolios and increased emphasis on domestic production to mitigate cost exposure. Furthermore, the tariff revisions have prompted stakeholders to reassess long-term procurement strategies and evaluate the feasibility of integrating vertically aligned manufacturing processes.

From a cost perspective, the imposed duties are likely to pressure research and development budgets, potentially delaying innovation cycles and impacting pricing strategies across the sector. In response, many organizations are exploring alternative sourcing routes, negotiating supplier contracts to spread tariff impact, and investing in localized manufacturing facilities. Such strategic adjustments may entail increased collaboration with regional partners and adoption of modular design principles to reduce reliance on imported assemblies. Meanwhile, the prospect of higher device prices could alter customer purchasing behavior, prompting healthcare providers to prioritize cost-effective fluorescence solutions or alternative diagnostic modalities.

Ultimately, the cumulative impact of the 2025 tariffs underscores the need for proactive risk management and adaptive business models. By enhancing supply chain transparency, diversifying supplier networks, and aligning investment decisions with tariff scenarios, industry participants can navigate emerging trade barriers while sustaining innovation momentum.

Deriving Key Insights from Sectoral Segmentation Spanning Technology, Fluorophore Type, Application Modalities, and End-User Verticals for Fluorescence Market

Segmenting the fluorescence market by technology reveals distinct growth drivers and adoption profiles across imaging systems, spectroscopy platforms, and fluorescent dyes and agents. Fluorescence imaging systems have gained prominence due to their ability to deliver real-time visual feedback in surgical suites, while advances in spectroscopy techniques support detailed molecular analysis in laboratory settings. Meanwhile, fluorescent dyes and agents continue to evolve, offering improved photostability and target specificity that enhance both diagnostic accuracy and therapeutic monitoring. This technology-based perspective enables stakeholders to identify where innovation is most concentrated and where technical barriers may still require attention.

Considering the type of fluorophore employed, a clear dichotomy emerges between endogenous fluorophores and exogenous fluorophores. Endogenous compounds, which leverage naturally occurring biomolecules for signal generation, offer the advantage of reduced risk of adverse reactions, making them well suited for repeated imaging procedures. Exogenous fluorophores, in contrast, provide greater flexibility through chemical design, enabling targeted delivery and multifunctional labeling. This distinction influences device development pathways and regulatory considerations, as product safety, imaging depth, and multiplexing capabilities must be balanced against manufacturing and validation requirements.

When application comes into focus, the market spans fluorescence in catheters, fluorescence-guided surgery across cardiovascular surgery, neurosurgery, oncology surgery, and orthopedic surgery, imaging and diagnostics through endoscopic fluorescence imaging, fluorescence microscopy, fluorescence-based ophthalmic imaging, and in vivo fluorescence imaging, and therapeutic uses such as photodynamic therapy. Meanwhile, end-user segmentation underscores the varied purchasing and usage patterns of diagnostic laboratories, hospitals and clinics, and research and academic institutes. By integrating these four segmentation lenses, stakeholders can gain a holistic understanding of market priorities, uncover unmet needs, and tailor strategies that address the nuances of each segment, ensuring informed decisions across product development and commercial deployment.

Uncovering Regional Dynamics and Growth Patterns Across the Americas, Europe Middle East Africa, and Asia-Pacific to Drive Strategic Market Expansion

Regional dynamics in the Americas continue to be shaped by robust investment in healthcare infrastructure and significant innovation clusters in North America. The United States remains at the forefront of fluorescence-enabled medical device development, supported by strong venture funding, university research, and favorable reimbursement models. Canada follows with increasing adoption driven by national health priorities and collaborative research initiatives. In Latin American markets, economic variability and regulatory divergence present both challenges and opportunities, as local manufacturers gradually embrace fluorescence technologies to meet the rising demand for advanced diagnostic and surgical solutions in major urban centers.

Shifting attention to Europe, the Middle East, and Africa, the diversity of regulatory frameworks and healthcare funding models necessitates adaptive market entry strategies. Western European countries benefit from coordinated regulatory alignment and established clinical pathways for fluorescence-guided interventions, while emerging markets in Eastern Europe and the Middle East exhibit growing interest fueled by government-led healthcare modernization programs. In Africa, infrastructure constraints slow widespread adoption but also create potential for strategic partnerships aimed at pilot implementations in urban centers with academic medical facilities.

Asia-Pacific stands out as a rapidly expanding region, driven by rising healthcare expenditure, growing middle-class populations, and national initiatives to boost local device manufacturing. Key markets such as China, Japan, South Korea, and India are investing heavily in research and development, with an emphasis on indigenously produced fluorophores and imaging systems. At the same time, cost sensitivity in certain markets encourages adoption of portable point-of-care devices and simplified fluorescence-guided tools. Recognizing these regional distinctions empowers organizations to align product portfolios, navigate complex regulatory landscapes, and tailor commercial approaches that resonate with local dynamics.

Highlighting Competitive Strategies and Innovation of Leading Players in Medical Device Fluorescence to Reveal Differentiation and Collaboration Opportunities

Leading companies in the fluorescence medical device arena have demonstrated varied strategic approaches to maintain competitive advantage and foster innovation. Major device manufacturers have prioritized expansion of their fluorescence imaging portfolios through both in-house development and acquisition of specialized technology firms. By integrating next-generation detectors and AI-driven software into existing platforms, these organizations have enhanced diagnostic accuracy and streamlined clinical workflows. Simultaneously, chemical suppliers have invested in developing advanced fluorescent dyes with superior biocompatibility and multiplexing capabilities, forging partnerships with device makers to co-develop bundled solutions that meet stringent regulatory requirements.

Several key players have pursued geographical diversification, establishing regional research and production facilities to mitigate trade and tariff challenges while improving responsiveness to local market needs. Strategic alliances between imaging system producers and academic research centers have led to cutting-edge proof-of-concept studies, accelerating translation of novel fluorophores into clinical applications. Moreover, a number of companies have leveraged collaborative frameworks to coalesce around standardization efforts, aiming to harmonize data formats and performance metrics across different fluorescence modalities.

In addition, the competitive landscape is witnessing increased investment in personalized medicine applications, with firms exploring fluorescence-based tools for intraoperative guidance in oncology and neurosurgery. By targeting specific clinical domains, these organizations aim to differentiate their offerings through tailored protocols, comprehensive training programs, and post-market surveillance initiatives. Collectively, these strategic maneuvers underscore the dynamic nature of the market and highlight the importance of continuous innovation, cross-sector collaboration, and customer-centric solution development in sustaining long-term growth and market leadership.

Strategic Recommendations for Industry Leaders to Accelerate Innovation, Navigate Regulations, and Strengthen Market Position in Fluorescence Technologies

To capitalize on the evolving fluorescence landscape, industry leaders should adopt a multifaceted strategy that balances innovation with operational resilience. First, strengthening supply chain robustness through diversification of component sourcing and exploration of regional manufacturing hubs can mitigate risks associated with tariff volatility and logistical disruptions. At the same time, targeted investment in research and development of next-generation fluorophores and modular imaging platforms will position organizations at the vanguard of clinical innovation, enhancing their ability to address complex diagnostic and therapeutic challenges.

Second, fostering strategic collaborations is critical. Engaging with academic institutions, clinical research networks, and regulatory bodies early in the product development cycle can streamline validation processes and accelerate market access. Co-development partnerships with end-users enable iterative product refinement based on real-world feedback, driving adoption and creating compelling value propositions. Simultaneously, proactive regulatory engagement-such as participating in guidance consultations and standard-setting committees-will help shape favorable approval pathways and ensure compliance with emerging guidelines.

Third, companies should prioritize digital transformation by integrating artificial intelligence, cloud-based analytics, and telemedicine capabilities into their fluorescence solutions. These enhancements can boost workflow efficiency, support remote diagnostics, and unlock new applications in personalized medicine. Finally, delivering comprehensive training and support programs for healthcare providers will facilitate seamless clinical integration, minimize user resistance, and maximize patient benefits. By implementing these actionable recommendations, industry participants can navigate current headwinds and lay the groundwork for sustainable growth and differentiation in the fluorescence medical device sector.

Research Methodology Highlighting Primary and Secondary Data Collection, Validation Processes, and Analytical Frameworks Informing Fluorescence Market Insights

The research methodology underpinning this report combines rigorous primary and secondary data collection to ensure comprehensive coverage and depth of insight. Primary research involved structured interviews with key opinion leaders, including biomedical engineers, clinical practitioners, regulatory specialists, and procurement managers. In parallel, tailored surveys were administered to device manufacturers, chemical suppliers, and end-users to capture firsthand perspectives on performance criteria, adoption drivers, and market challenges. This qualitative input provided invaluable context and validated emerging themes in fluorescence technology development and commercialization.

Secondary research encompassed an extensive review of publicly available sources, such as peer-reviewed journal articles, patent filings, regulatory guidelines, conference proceedings, and corporate disclosures. Detailed analysis of product approvals and clinical trial registries supplemented the understanding of regulatory landscapes across major geographies. Additionally, market intelligence databases were consulted to map competitive positioning, historical innovation trajectories, and partnership activities, ensuring a well-rounded view of industry dynamics.

To uphold data integrity, all quantitative and qualitative data points underwent triangulation through cross-referencing among multiple sources. Validation processes included consistency checks, logic screening, and reconciliation with expert feedback to eliminate discrepancies. Analytical frameworks-such as SWOT analysis, PESTLE evaluation, and value chain mapping-were applied to structure insights and facilitate strategic interpretation. This robust methodological approach guarantees that the findings and recommendations presented are grounded in reliable evidence and reflective of real-world market conditions.

Synthesizing Critical Findings and Projecting Strategic Implications to Guide Stakeholders Towards Future Innovations and Sustainable Growth in Fluorescence

This executive summary has distilled the most impactful developments in medical device fluorescence, highlighting technological breakthroughs in imaging systems, spectroscopy, and fluorophore design. It has examined forthcoming tariff adjustments and their potential to reshape supply chains and cost structures. By analyzing segmentation across technology, fluorophore type, application domains, and end-user groups, it has offered a nuanced perspective on market priorities. Regional insights detailed the differing dynamics of the Americas, Europe Middle East and Africa, and Asia-Pacific, while corporate analysis showcased how leading players are leveraging partnerships, localized manufacturing, and product innovation to maintain competitive advantage. The actionable recommendations provide a clear roadmap for navigating regulatory complexities, strengthening resilience, and driving continuous innovation.

As stakeholders contemplate the next phase of growth, the strategic implications of these findings underscore the importance of agility, collaboration, and patient-centric development. Organizations that proactively adjust sourcing strategies, engage with regulatory authorities, and invest in digital integration will be better positioned to capture emerging opportunities. Ultimately, the integration of fluorescence technologies into mainstream clinical practice promises enhanced diagnostic accuracy, more targeted therapeutic interventions, and improved patient outcomes. By synthesizing these insights, decision-makers can align their efforts to drive sustainable value creation in the rapidly evolving fluorescence-enabled medical device market.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Expansion of near-infrared fluorescence probes for deeper tissue imaging in oncology applications
  • 5.2. Integration of near-infrared fluorescence imaging with robotic surgery systems to enhance tumor visualization
  • 5.3. Adoption of AI-powered fluorescence analysis software for enhanced tissue differentiation
  • 5.4. Emergence of wearable fluorescence biosensors for continuous monitoring of metabolic biomarkers
  • 5.5. Collaborations between hospitals and biotech firms to commercialize novel fluorescent contrast agents
  • 5.6. Advances in real-time intraoperative fluorescence-guided tumor margin detection tools for oncology
  • 5.7. Development of dual-modality clinical imaging platforms combining fluorescence and ultrasound modalities
  • 5.8. Growth of handheld fluorescence imaging devices for vascular mapping and dermatological assessments
  • 5.9. Regulatory harmonization and standardization efforts driving global commercialization of fluorescence medical devices
  • 5.10. Rising demand for three-dimensional fluorescence microscopy in minimally invasive diagnostic procedures

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Fluorescence in Medical Device Market, by Technology

  • 8.1. Introduction
  • 8.2. Fluorescence Imaging Systems
  • 8.3. Fluorescence Spectroscopy
  • 8.4. Fluorescent Dyes & Agents

9. Fluorescence in Medical Device Market, by Fluorophore Type

  • 9.1. Introduction
  • 9.2. Endogenous Fluorophores
  • 9.3. Exogenous Fluorophores

10. Fluorescence in Medical Device Market, by Application

  • 10.1. Introduction
  • 10.2. Fluorescence in Catheters
  • 10.3. Fluorescence-Guided Surgery
    • 10.3.1. Cardiovascular Surgery
    • 10.3.2. Neurosurgery
    • 10.3.3. Oncology Surgery
    • 10.3.4. Orthopedic Surgery
  • 10.4. Imaging & Diagnostics
    • 10.4.1. Endoscopic Fluorescence Imaging
    • 10.4.2. Fluorescence Microscopy
    • 10.4.3. Fluorescence-Based Ophthalmic Imaging
    • 10.4.4. In Vivo Fluorescence Imaging
  • 10.5. Therapeutic

11. Fluorescence in Medical Device Market, by End-User

  • 11.1. Introduction
  • 11.2. Diagnostic Laboratories
  • 11.3. Hospitals & Clinics
  • 11.4. Research & Academic Institutes

12. Americas Fluorescence in Medical Device Market

  • 12.1. Introduction
  • 12.2. United States
  • 12.3. Canada
  • 12.4. Mexico
  • 12.5. Brazil
  • 12.6. Argentina

13. Europe, Middle East & Africa Fluorescence in Medical Device Market

  • 13.1. Introduction
  • 13.2. United Kingdom
  • 13.3. Germany
  • 13.4. France
  • 13.5. Russia
  • 13.6. Italy
  • 13.7. Spain
  • 13.8. United Arab Emirates
  • 13.9. Saudi Arabia
  • 13.10. South Africa
  • 13.11. Denmark
  • 13.12. Netherlands
  • 13.13. Qatar
  • 13.14. Finland
  • 13.15. Sweden
  • 13.16. Nigeria
  • 13.17. Egypt
  • 13.18. Turkey
  • 13.19. Israel
  • 13.20. Norway
  • 13.21. Poland
  • 13.22. Switzerland

14. Asia-Pacific Fluorescence in Medical Device Market

  • 14.1. Introduction
  • 14.2. China
  • 14.3. India
  • 14.4. Japan
  • 14.5. Australia
  • 14.6. South Korea
  • 14.7. Indonesia
  • 14.8. Thailand
  • 14.9. Philippines
  • 14.10. Malaysia
  • 14.11. Singapore
  • 14.12. Vietnam
  • 14.13. Taiwan

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. ADVACAM s.r.o.
    • 15.3.2. Arthrex, Inc.
    • 15.3.3. Bruker Corporation
    • 15.3.4. Carl Zeiss AG.
    • 15.3.5. Getinge AB
    • 15.3.6. Hamamatsu Photonics K.K.
    • 15.3.7. KARL STORZ SE & Co. KG
    • 15.3.8. Leica Microsystems GmbH
    • 15.3.9. LI-COR Biotech, LLC
    • 15.3.10. Mauna Kea Technologies
    • 15.3.11. Medtronic International Trading Sarl
    • 15.3.12. MolecuLight Inc.
    • 15.3.13. Olympus Corporation of the Americas
    • 15.3.14. OnLume Inc.
    • 15.3.15. Optomedic.
    • 15.3.16. PerkinElmer U.S. LLC
    • 15.3.17. PicoQuant GmbH
    • 15.3.18. Shimadzu Corporation
    • 15.3.19. Stryker Corporation
    • 15.3.20. Xuzhou Hengjia Electronic Technology Co., Ltd.
    • 15.3.21. SurgiMab SAS

16. ResearchAI

17. ResearchStatistics

18. ResearchContacts

19. ResearchArticles

20. Appendix

LIST OF FIGURES

  • FIGURE 1. FLUORESCENCE IN MEDICAL DEVICE MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 14. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 16. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. FLUORESCENCE IN MEDICAL DEVICE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 22. FLUORESCENCE IN MEDICAL DEVICE MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 23. FLUORESCENCE IN MEDICAL DEVICE MARKET: RESEARCHAI
  • FIGURE 24. FLUORESCENCE IN MEDICAL DEVICE MARKET: RESEARCHSTATISTICS
  • FIGURE 25. FLUORESCENCE IN MEDICAL DEVICE MARKET: RESEARCHCONTACTS
  • FIGURE 26. FLUORESCENCE IN MEDICAL DEVICE MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. FLUORESCENCE IN MEDICAL DEVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE IMAGING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE IMAGING SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE SPECTROSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE SPECTROSCOPY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENT DYES & AGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENT DYES & AGENTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY ENDOGENOUS FLUOROPHORES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY ENDOGENOUS FLUOROPHORES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY EXOGENOUS FLUOROPHORES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY EXOGENOUS FLUOROPHORES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE IN CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE IN CATHETERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY NEUROSURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY ONCOLOGY SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY ONCOLOGY SURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY ENDOSCOPIC FLUORESCENCE IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY ENDOSCOPIC FLUORESCENCE IMAGING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE MICROSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE MICROSCOPY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-BASED OPHTHALMIC IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-BASED OPHTHALMIC IMAGING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IN VIVO FLUORESCENCE IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IN VIVO FLUORESCENCE IMAGING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY THERAPEUTIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 62. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 63. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 64. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 65. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 66. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 67. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 68. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 69. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 70. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 71. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 72. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 73. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. AMERICAS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 75. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 76. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 77. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 78. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 79. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 80. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 81. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 82. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 83. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 84. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 85. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 86. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 87. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 88. UNITED STATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 89. CANADA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 90. CANADA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 91. CANADA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 92. CANADA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 93. CANADA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 94. CANADA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 95. CANADA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 96. CANADA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 97. CANADA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 98. CANADA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 99. CANADA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 100. CANADA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 101. MEXICO FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 102. MEXICO FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 103. MEXICO FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 104. MEXICO FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 105. MEXICO FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 106. MEXICO FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 107. MEXICO FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 108. MEXICO FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 109. MEXICO FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 110. MEXICO FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 111. MEXICO FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 112. MEXICO FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 113. BRAZIL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 114. BRAZIL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 115. BRAZIL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 116. BRAZIL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 117. BRAZIL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 118. BRAZIL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 119. BRAZIL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 120. BRAZIL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 121. BRAZIL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 122. BRAZIL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 123. BRAZIL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 124. BRAZIL FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 125. ARGENTINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 126. ARGENTINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 127. ARGENTINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 128. ARGENTINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 129. ARGENTINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 130. ARGENTINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 131. ARGENTINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 132. ARGENTINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 133. ARGENTINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 134. ARGENTINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 135. ARGENTINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 136. ARGENTINA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 152. UNITED KINGDOM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 153. UNITED KINGDOM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. UNITED KINGDOM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 155. UNITED KINGDOM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 156. UNITED KINGDOM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 157. UNITED KINGDOM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 158. UNITED KINGDOM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 159. UNITED KINGDOM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 160. UNITED KINGDOM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 161. UNITED KINGDOM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 162. UNITED KINGDOM FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 163. GERMANY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 164. GERMANY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 165. GERMANY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. GERMANY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 167. GERMANY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 168. GERMANY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 169. GERMANY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 170. GERMANY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 171. GERMANY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 172. GERMANY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 173. GERMANY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 174. GERMANY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 175. FRANCE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 176. FRANCE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 177. FRANCE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. FRANCE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 179. FRANCE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 180. FRANCE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 181. FRANCE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 182. FRANCE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 183. FRANCE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 184. FRANCE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 185. FRANCE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 186. FRANCE FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 187. RUSSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 188. RUSSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 189. RUSSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. RUSSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 191. RUSSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 192. RUSSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 193. RUSSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 194. RUSSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 195. RUSSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 196. RUSSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 197. RUSSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 198. RUSSIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 199. ITALY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 200. ITALY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 201. ITALY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. ITALY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 203. ITALY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 204. ITALY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 205. ITALY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 206. ITALY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 207. ITALY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 208. ITALY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 209. ITALY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 210. ITALY FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 211. SPAIN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 212. SPAIN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 213. SPAIN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. SPAIN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 215. SPAIN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 216. SPAIN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 217. SPAIN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 218. SPAIN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 219. SPAIN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 220. SPAIN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 221. SPAIN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 222. SPAIN FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 236. SAUDI ARABIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. SAUDI ARABIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. SAUDI ARABIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 242. SAUDI ARABIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 244. SAUDI ARABIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 246. SAUDI ARABIA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 248. SOUTH AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. SOUTH AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. SOUTH AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 253. SOUTH AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 254. SOUTH AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 255. SOUTH AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 256. SOUTH AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 257. SOUTH AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 258. SOUTH AFRICA FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 259. DENMARK FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 260. DENMARK FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 261. DENMARK FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. DENMARK FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 263. DENMARK FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 264. DENMARK FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 265. DENMARK FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 266. DENMARK FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 267. DENMARK FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 268. DENMARK FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 269. DENMARK FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 270. DENMARK FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 271. NETHERLANDS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 272. NETHERLANDS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 273. NETHERLANDS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. NETHERLANDS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 275. NETHERLANDS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. NETHERLANDS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 277. NETHERLANDS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 278. NETHERLANDS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 279. NETHERLANDS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 280. NETHERLANDS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 281. NETHERLANDS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 282. NETHERLANDS FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 283. QATAR FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 284. QATAR FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 285. QATAR FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. QATAR FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUOROPHORE TYPE, 2025-2030 (USD MILLION)
  • TABLE 287. QATAR FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. QATAR FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 289. QATAR FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2018-2024 (USD MILLION)
  • TABLE 290. QATAR FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY FLUORESCENCE-GUIDED SURGERY, 2025-2030 (USD MILLION)
  • TABLE 291. QATAR FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 292. QATAR FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY IMAGING & DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 293. QATAR FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 294. QATAR FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 295. FINLAND FLUORESCENCE IN MEDICAL DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLIO